Crestline Management, L.P. — Q2 2025 13F-HR

← Crestline Management, L.P.

Q2 2025 · 13F-HR

Crestline Management, L.P.holdings as filed

Filed 2025-08-14 · accession 0001315863-25-000627

$62.6M

Reported value

Positions

2025-06-30

Period end

View analyzed profile →PRO

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
24823R105	DNLI	DENALI THERAPEUTICS INC	$54.0M	86.3%	3,860,732	Common	SOLE
799566104	SANA	SANA BIOTECHNOLOGY INC	$6.6M	10.6%	2,420,937	Common	SOLE
282914100	EGHT	8X8 INC NEW	$1.9M	3.10%	990,580	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.